SCHEMBL6948711

SCHEMBL6948711

Cc1ccc2cc(N3CCNCC3)ccc2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.57
HTR3B O95264 3/20 0.57
HTR3A P46098 3/20 0.57
HTR3D Q70Z44 3/20 0.57
HTR3C Q8WXA8 3/20 0.57
HTR5A P47898 1/20 0.57
SIGMAR1 Q99720 1/20 0.57
ADRB1 P08588 7/20 0.54
HTR1A P08908 2/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
NCF1 P14598 2/20 0.48
ADRB2 P07550 1/20 0.48
CYP1A2 P05177 3/20 0.47
CHRNB2 P17787 1/20 0.46
CHRNA4 P43681 1/20 0.46
OPRL1 P41146 1/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28136975 0.81 PSMB5 (0.53) NCF1CYP1A2KDM4ELMNAPOLB
SCHEMBL20582304 0.81 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL21979979 0.81 HTR3E (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL28905085 0.78 HTR3E (0.53) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL20859429 0.77 HTR3E (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL15534306 0.77 HTR3A (0.69) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL22790262 0.77 HTR3E (0.51) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL30594984 0.77 ADRB1 (0.53) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL6502486 0.76 PDE3B (0.59) KDM4EALDH1A1USP2HSD17B10
Hydrochloric Acid SCHEMBL15534114 0.76 HTR3A (0.67) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105712945-B 2-substituted oxy-5-methylsulfonyl aryl piperazine amide analogue and preparation method and application thereof 上海翰森生物医药科技有限公司 2020-12-01 CN disclosed
EP-1311503-A1 CHROMENONE DERIVATIVES AND THEIR USE FOR TREATING DISEASES IN CONJUNCTION WITH 5-HTA1 RECEPTORS AND/OR DOPAMINE D2 RECEPTORS MERCK PATENT GmbH (DE) 2003-05-21 EP disclosed
WO-2002016354-A1 CHROMENONE DERIVATIVES AND THEIR USE FOR TREATING DISEASES IN CONJUNCTION WITH 5-HTA1 RECEPTORS AND/OR DOPAMINE D2 RECEPTORS MERCK PATENT GMBH (DE) 2002-02-28 WO disclosed